Congenital Platelets Abnormality clinical trials at UC Health
1 research study open to new patients
-
Clinical Performance Evaluation of T-TAS 01 PL Chip
open to eligible people ages 21 years and up
This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.
at UCSF
Last updated: